Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities
Type
Physical Book
Language
English
Pages
160
Format
Paperback
Dimensions
21.6 x 14.0 x 0.9 cm
Weight
0.19 kg.
ISBN13
9781934899397

Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Yali Friedman (Author) · Drugpatentwatch.com · Paperback

Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities - Friedman, Yali

New Book

£ 27.18

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Friday, August 02 and Wednesday, August 14.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities"

Make Better Decisions helps generic and branded companies alike find and evaluate drug market entry opportunities.Billions of dollars can change hands when key drug patents expire and generics launch. Brands can experience precipitous revenue erosion as generic drugs rapidly gain market share. All the while patients, physicians, payers, pharmacists, and other healthcare stakeholders must race to keep up.Make Better Decisions answers the following questions to help you adapt: When will key drug patents expire? How can I write stronger patents? How can I defeat drug patents? How can I find, evaluate, and plan for generic market entry opportunities? How can I find proprietary out-of-court settlements and deal terms? Comprehensive and actionable coverage of commercial, legal, and regulatory factors builds a solid foundation for strategic thinking. Diverse case studies build on this groundwork by analyzing and explaining real-work examples to form the underpinning for your tactical plans.Author Yali Friedman, Ph.D. has more than 20 years experience providing business intelligence to life science companies. He was recently named one of the 100 most influential people in biotechnology by Scientific American. He is also author of the MBA-level textbook Building Biotechnology and publisher of the Journal of Commercial Biotechnology.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews